National pharmacovigilance systems should be closely linked to national drug regulatory systems. To function properly, a national safety monitoring programme for herbal medicines should be operated alongside an effective national drug regulatory system with the will and the potential to react to signals emanating from reports of adverse effects of herbal medicines and to take proper regulatory measures.